Dr. Holger Laux
Bis 2021, Associate Director Viral Vector Process Development, CSL Behring
Basel, Schweiz
Werdegang
Berufserfahrung von Holger Laux
Bis heute 2 Jahre und 11 Monate, seit Jan. 2022
Director Viral Vector Process Development
CSL Behring Innovation GmbH
2 Jahre und 3 Monate, Okt. 2019 - Dez. 2021
Associate Director Viral Vector Process Development
CSL Behring2 Jahre und 6 Monate, Apr. 2017 - Sep. 2019
Global Cell Line Development Network Leader
Novartis Pharma AG
- Leading global cell line development network - Establish and align global standards, workflows, processes and technologies - Leading and improving Novartis mammalian expression platform - Develop and drive new technologies in the field of AAV production - Improving the expression of recombinant therapeutic proteins - Establishment of an AAV expression platform suitable for commercial production - Project leader of recombinant therapeutic protein projects
3 Jahre und 7 Monate, Sep. 2013 - März 2017
Fellow / Laboratory Head
Novartis Pharma AG
I am supervising a team of scientists. My laboratory is involved in executing pipeline projects, improving Novartis CHO cell lines and performing various routine molecular biology assays. Additionally I am responsible for several pipeline projects, including the coordination of a variety of development activities and active participation in CMC teams. Furthermore I am leading the Novartis “mammalian expression platform” (developing long term strategy, evaluation/implementation of novel technologies).
5 Jahre und 3 Monate, Juli 2008 - Sep. 2013
Principal Scientist / Laboratory Head
Novartis Pharma AG
Lead a laboratory with several scientists, technicians and students; mentoring of a postdoc; gene expression screening and diagnostic marker identification using microarrays and real-time RT-PCR; next generation sequencing; cell line engineering using shRNA and knockout techniques; generation and charcterisation of recombinant mammalian cell lines for the production of biopharmaceuticals; process automation; project management (external and internal projects); ELN implementation; miRNA analysis
1 Jahr und 6 Monate, Jan. 2007 - Juni 2008
Postdoctoral fellow
SGUL
I am responsible for the characterising of different blood vessel cells (identifying and validating biomarkers using whole genome microarrays). Furthermore I compare the gene expression profile of different knockout mouse lines using whole genome microarrays and real-time RT-PCR.
2 Jahre, Jan. 2005 - Dez. 2006
Researcher
LGC
My responsibilities were the detection of gene expression differences, biomarkers and signalling pathways in a toxicogenomic model system using whole genome microarrays working under GMP and GLP. I was also responsible for the development of microarray quality and reference standards.
Ausbildung von Holger Laux
4 Jahre und 6 Monate, Juli 2000 - Dez. 2004
Cancer Research
Technical University Munich
Gene expression, Microarray, real-time RT-PCR, siRNA, Immunoblotting, Transfection, Cell culture
3 Monate, Jan. 2000 - März 2000
Infectious biology
University of Minnesota
Examination of adhesion and invasion of human granulocytic ehrlichiosis
1 Jahr und 1 Monat, Okt. 1998 - Okt. 1999
Infectious biology
Max von Pettenkofer-Institut
“Differential expression of outer surface proteins by Borrelia burgdorferi“
6 Jahre, Nov. 1993 - Okt. 1999
Biology
Ludwig-Maximilians-University Munich
Genetics, Microbiology, Immunology, Biochemistry, Infectious diseases
Sprachen
Englisch
Fließend
Deutsch
Muttersprache